Metagenomi Therapeutics, Inc. (NASDAQ:MGX) has 56 institutional investors with active 13F positions as of December 2025.
| Owner Name | Date | Shares Held | Change (QoQ) | Change (%) | Value (USD) |
|---|---|---|---|---|---|
| VANGUARD GROUP INC | 31 Dec, 2025 | 1,270,246 | 28,736 | 2.31% | $2,057,799.00 |
| VANGUARD CAPITAL MANAGEMENT LLC | 31 Dec, 2025 | 1,057,944 | 1,057,944 | 0.00% | $1,417,645.00 |
| RENAISSANCE TECHNOLOGIES LLC | 31 Dec, 2025 | 787,900 | 159,500 | 25.38% | $1,055,786.00 |
| RENAISSANCE TECHNOLOGIES LLC | 31 Dec, 2025 | 628,400 | 461,400 | 276.29% | $1,018,008.00 |
| Catalio Capital Management, LP | 31 Dec, 2025 | 528,993 | 0 | 0.00% | $856,969.00 |
| Catalio Capital Management, LP | 31 Dec, 2025 | 528,993 | 0 | 0.00% | $708,851.00 |
| Peapod Lane Capital LLC | 31 Dec, 2025 | 516,761 | 19,108 | 3.84% | $682,915.00 |
| Peapod Lane Capital LLC | 31 Dec, 2025 | 497,653 | -16,162 | -3.15% | $806,198.00 |
| TWO SIGMA INVESTMENTS, LP | 31 Dec, 2025 | 496,767 | 55,379 | 12.55% | $665,668.00 |
| TWO SIGMA INVESTMENTS, LP | 31 Dec, 2025 | 441,388 | 233,860 | 112.69% | $715,049.00 |
| JANE STREET GROUP, LLC | 31 Dec, 2025 | 433,859 | 335,604 | 341.56% | $702,851.00 |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 31 Dec, 2025 | 395,800 | 0 | 0.00% | $530,372.00 |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 31 Dec, 2025 | 395,800 | 200,000 | 102.15% | $641,196.00 |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 31 Dec, 2025 | 382,153 | 382,153 | 0.00% | $512,085.00 |
| GEODE CAPITAL MANAGEMENT, LLC | 31 Dec, 2025 | 358,200 | 52,292 | 17.09% | $480,157.00 |
| GEODE CAPITAL MANAGEMENT, LLC | 31 Dec, 2025 | 305,908 | 14,018 | 4.80% | $495,765.00 |
| PURA VIDA INVESTMENTS, LLC | 31 Dec, 2025 | 264,391 | 0 | 0.00% | $428,313.00 |
| PURA VIDA INVESTMENTS, LLC | 31 Dec, 2025 | 264,391 | 0 | 0.00% | $354,284.00 |
| MILLENNIUM MANAGEMENT LLC | 31 Dec, 2025 | 235,185 | -75,507 | -24.30% | $381,000.00 |
| BlackRock, Inc. | 31 Dec, 2025 | 230,134 | 5,993 | 2.67% | $308,379.00 |